Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PT Finusolprima Farma Internasional is an Indonesian pharmaceutical company specializing in the production of large volume parenterals (LVP) and clinical nutrition. Established in 1993 and acquired by PT Kalbe Farma Tbk in 1997, the company operates as a key manufacturing arm for essential hospital supplies. Its core product line includes intravenous fluids such as saline, dextrose, and Ringer's lactate, which are critical for fluid replacement and electrolyte balance. The company's manufacturing facility is located in Bekasi, West Java, and adheres to Good Manufacturing Practice (GMP) standards for sterile products. Finusolprima serves both the Indonesian domestic market and international export markets, contributing to the regional supply of life-saving infusion therapies. Through its integration with Kalbe Farma, the company leverages extensive distribution networks to reach healthcare providers across the archipelago.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Finusolprima Farma Indonesia.